CD33 and acute myeloid leukemia: Further corroborating this possibility, we observed a correlation between IFNB1 levels in isolated CD33+ leukemic blasts and whole PBMCs from 22 AML patients (R = 0.4243, p = 0.0491) (Supplemental Fig. 3B).